Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer
2046.0000 2.60 (0.13%)
NSE Sep 15, 2025 15:31 PM
Volume: 594.6K
 

logo
Lupin Ltd.
05 Aug 2022
2046.00
0.13%
ICICI Securities Limited
Lupin’s Q1FY23 performance was disappointing on profitability front. It reported its worst-ever EBITDA margin of 6.2% (I-Sec: 7.3%) due to restructuring in the US as well as continuous impact of inflation on raw materials and freight. US revenue sharply declined to US$121mn (I-Sec: 180mn) vs US$172/181mn YoY/QoQ on ~US$40-50mn one-time impact of restructuring, inventory write-offs and withdrawal of products.
Lupin Ltd. has an average target of 2326.00 from 8 brokers.
More from Lupin Ltd.
Recommended